These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18989054)

  • 21. Coronary bifurcation lesions.
    Sharma SK; Kini AS
    Cardiol Clin; 2006 May; 24(2):233-46, vi. PubMed ID: 16781940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coronary atherectomy. An essential tool for specific indications].
    Coste P; Roudaut R; Besse P; Bonnet J
    Arch Mal Coeur Vaiss; 1999 Nov; 92(11 Suppl):1563-70. PubMed ID: 10598236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary bifurcation lesions: innovative approaches and the future of bifurcation devices.
    Cortese B; Limbruno U
    Future Cardiol; 2010 Mar; 6(2):221-30. PubMed ID: 20230263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting stents: a comprehensive appraisal.
    Butt M; Connolly D; Lip GY
    Future Cardiol; 2009 Mar; 5(2):141-57. PubMed ID: 19371189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results.
    Rathore S; Matsuo H; Terashima M; Kinoshita Y; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura Y; Katoh O; Suzuki T
    Catheter Cardiovasc Interv; 2010 May; 75(6):919-27. PubMed ID: 20432398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting balloons for side branch stenting during bifurcation percutaneous coronary intervention.
    Kherada N; Mehran R
    Minerva Cardioangiol; 2013 Feb; 61(1):71-9. PubMed ID: 23381382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Delayed repair of the lateral branch ostium after stent implantation into the great portion of the coronary artery in bifurcation stenosis].
    Oleĭnik AO; Shitikov IV; Titkov IV; Bobrov AV; Iakimova NA
    Ter Arkh; 2007; 79(4):57-8. PubMed ID: 17564021
    [No Abstract]   [Full Text] [Related]  

  • 30. Transradial treatment of bifurcation coronary disease using the Multi-Link Frontier bifurcation stent system.
    Aziz S; Morris JL
    J Invasive Cardiol; 2005 Oct; 17(10):E1-3. PubMed ID: 16208040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery bifurcation lesion classifications, interventional techniques and clinical outcome.
    Movahed MR
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):261-74. PubMed ID: 18248279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Left main coronary artery stenosis].
    Sheiban I; Biondi-Zoccai GG; Moretti C
    G Ital Cardiol (Rome); 2008 Oct; 9(10):684-9. PubMed ID: 18942556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous treatment of coronary bifurcation lesions in the era of drug-eluting stents.
    Costa RA; Moussa ID
    Minerva Cardioangiol; 2006 Oct; 54(5):577-89. PubMed ID: 17019395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of parent vessel - side branch distal angle on restenosis rates after main vessel stenting in coronary bifurcation lesion.
    Gil RJ; Vassilev D; Rzezak J; Słysz A; Krzyzewski R; Kulawik T
    Kardiol Pol; 2009 Jan; 67(1):36-43; discussion 44-5. PubMed ID: 19253188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of rotational atherectomy.
    Cavusoglu E; Kini AS; Marmur JD; Sharma SK
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):485-98. PubMed ID: 15274159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Directional coronary atherectomy in 2005.
    Repetto A; Ferlini M; Ferrario M; Angoli L; Bramucci E
    Ital Heart J; 2005 Jun; 6(6):494-7. PubMed ID: 16008154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
    Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.